Lobbying

Lovelace Biomedical Research Institute's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Environmental/Superfund.

Lovelace Biomedical Research Institute

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Lovelace Biomedical Research Institute lobbying by quarter
Lovelace Biomedical Research Institute lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Budget and appropriations$150K · 15 reports
  • Environment and Superfund$150K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Cassidy & Associates$300K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/16for Q2Cassidy & Associates$20K
04/12for Q1Cassidy & Associates$20K
01/15for Q4 2025Cassidy & Associates$20K
25/10/14for Q3 2025Cassidy & Associates$20K
25/07/18for Q2 2025Cassidy & Associates$20K
25/04/15for Q1 2025Cassidy & Associates$20K
25/01/17for Q4 2024Cassidy & Associates$20K
24/10/15for Q3 2024Cassidy & Associates$20K
24/07/18for Q2 2024Cassidy & Associates$20K
24/04/17for Q1 2024Cassidy & Associates$20K
24/01/19for Q4 2023Cassidy & Associates$20K
23/10/06for Q3 2023Cassidy & Associates$20K
23/07/14for Q2 2023Cassidy & Associates$20K
23/04/11for Q1 2023Cassidy & Associates$20K
23/01/11for Q4 2022Cassidy & Associates$20K